Here's what is coming soon to Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see soon on Diagnostic Imaging:
In our continued coverage of Breast Cancer Awareness month, breast imaging radiologist, Daniel Shekleton, M.D., from Raleigh Radiology in North Carolina examines recent investigations in the United Kingdom into the effects of launching annual mammography screening at age 40, underscoring the recommendations from the American College of Radiology and the Society of Breast Imaging. Look for his article later this week.
To read insights from his clinical colleague on breast imaging during COVID-19, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Staying knowledgeable of how a woman’s breast density affects imaging is critical, and knowing whether a patient has dense breast can influence your use of preoperative MRI. Investigators from University of Pennsylvania have examined in what circumstances this modality and technique works best. We explore their findings in an article that will appear later this week.
See our previous coverage of breast MRI here.
Corporatization is not new in radiology, but the trend is definitely growing. Diagnostic Imaging spoke this week with Dr. Rich Heller, associate chief medical officer, and Dr. Nina Kottler, vice president of clinical operations, with Radiology Partners about how corporatization benefits radiology as an industry and the impacts it can have at the local level. Keep an eye out for their video interview this week.
To view Diagnostic Imaging’s other video content, click here.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.